Literature DB >> 33381599

Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes.

Ming Lei1, Kashuai Lin2, Yaoqiu Pi2, Xiaomei Huang2, Lixin Fan1, Jun Huang2, Riguang Liu2, Lin Liu1, Xinning Shao1, Kaiyuan Hu1, Liuping Yang1, Shuguang Qin2, Feng He2.   

Abstract

INTRODUCTION: Previous studies of coronavirus disease 2019 (COVID-19) have focused on the general population. However, diabetes (DM) as one of the most common comorbidities is rarely studied in detail. This study is aimed at describing clinical characteristics and determining risk factors of ICU admission for COVID-19 patients with DM.
METHODS: Data were extracted from 288 adult patients with laboratory-confirmed COVID-19 from Guangzhou Eighth People's Hospital. Demographic characteristics, laboratory results, radiographic findings, complications, and treatments were collected and compared between DM and non-DM groups. Binary logistic regression was used to identify the risk factors associated with ICU admission for COVID-19 patients with DM or non-DM.
RESULTS: COVID-19 patients with DM showed as older ages, higher levels of C-reactive protein (CRP), myoglobin, alanine transaminase (ALT), and aspartate transaminase (AST). They were also more prone to transfer to the intensive care unit (ICU) for treatment. Multiple regression analysis showed that the following were the independent risk factors for COVID-19 patients with DM that received ICU admission: each 1-year increase in age (odds ratio (OR), 1.07; 95% CI, 1.02-1.13; P = 0.007), respiratory rate over 24 times per minute (OR, 5.22; 95% CI, 2.26-16.58; P = 0.016), HbA1c greater than 7% (OR, 4.58; 95% CI, 1.82-10.55; P = 0.012), and AST higher than 40 U/L (OR, 2.96; 95% CI, 1.58-8.85; P = 0.022). In addition, each 1-year increase in age (OR, 1.05; 95% CI, 1.01-1.10; P = 0.006), diarrhea (OR, 4.62; 95% CI, 2.01-9.36; P = 0.022), respiratory rate over 24 times per minute (OR, 5.13; 95% CI, 1.18-16.82; P = 0.035), CRP greater than 10 mg/L (OR, 5.19; 95% CI, 1.37-13.25, P = 0.009), and TnI higher than 0.03 μg/L (OR, 6.48; 95% CI, 1.17-21.38; P = 0.036) were risk factors for ICU admission of COVID-19 patients with non-DM.
CONCLUSIONS: The older age, respiratory rate over 24 times per minute, HbA1c greater than 7%, and AST higher than 40 U/L were risk factors of ICU admission for COVID-19 patients with diabetes. Investigating and monitoring these factors could assist in the risk stratification of COVID-19 patients with DM at an early stage.
Copyright © 2020 Ming Lei et al.

Entities:  

Mesh:

Year:  2020        PMID: 33381599      PMCID: PMC7755491          DOI: 10.1155/2020/5237840

Source DB:  PubMed          Journal:  J Diabetes Res            Impact factor:   4.011


  32 in total

Review 1.  [Cells of innate and adaptive immunity in type 2 diabetes and obesity].

Authors:  Juan Manuel Guzmán-Flores; Sergio López-Briones
Journal:  Gac Med Mex       Date:  2012 Jul-Aug       Impact factor: 0.302

Review 2.  Effects of Apelin Peptides on Diabetic Complications.

Authors:  Hong Chen; Chengyu Liu; Cheng Cheng; Ling Zheng; Kun Huang
Journal:  Curr Protein Pept Sci       Date:  2018       Impact factor: 3.272

3.  Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.

Authors:  Alberto Coppelli; Rosa Giannarelli; Michele Aragona; Giuseppe Penno; Marco Falcone; Giusy Tiseo; Lorenzo Ghiadoni; Greta Barbieri; Fabio Monzani; Agostino Virdis; Francesco Menichetti; Stefano Del Prato
Journal:  Diabetes Care       Date:  2020-08-11       Impact factor: 19.112

4.  Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.

Authors:  Chuan Qin; Luoqi Zhou; Ziwei Hu; Shuoqi Zhang; Sheng Yang; Yu Tao; Cuihong Xie; Ke Ma; Ke Shang; Wei Wang; Dai-Shi Tian
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

Review 5.  Primary prevention of cardiovascular disease: A review of contemporary guidance and literature.

Authors:  Jack Stewart; Gavin Manmathan; Peter Wilkinson
Journal:  JRSM Cardiovasc Dis       Date:  2017-01-01

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.

Authors:  Meng-Yuan Li; Lin Li; Yue Zhang; Xiao-Sheng Wang
Journal:  Infect Dis Poverty       Date:  2020-04-28       Impact factor: 4.520

8.  Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.

Authors:  Lihua Zhu; Zhi-Gang She; Xu Cheng; Juan-Juan Qin; Xiao-Jing Zhang; Jingjing Cai; Fang Lei; Haitao Wang; Jing Xie; Wenxin Wang; Haomiao Li; Peng Zhang; Xiaohui Song; Xi Chen; Mei Xiang; Chaozheng Zhang; Liangjie Bai; Da Xiang; Ming-Ming Chen; Yanqiong Liu; Youqin Yan; Mingyu Liu; Weiming Mao; Jinjing Zou; Liming Liu; Guohua Chen; Pengcheng Luo; Bing Xiao; Changjiang Zhang; Zixiong Zhang; Zhigang Lu; Junhai Wang; Haofeng Lu; Xigang Xia; Daihong Wang; Xiaofeng Liao; Gang Peng; Ping Ye; Jun Yang; Yufeng Yuan; Xiaodong Huang; Jiao Guo; Bing-Hong Zhang; Hongliang Li
Journal:  Cell Metab       Date:  2020-05-01       Impact factor: 27.287

9.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.

Authors:  Jing Yang; Ya Zheng; Xi Gou; Ke Pu; Zhaofeng Chen; Qinghong Guo; Rui Ji; Haojia Wang; Yuping Wang; Yongning Zhou
Journal:  Int J Infect Dis       Date:  2020-03-12       Impact factor: 3.623

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  7 in total

1.  Characterization and Determinant Factors of Critical Illness and In-Hospital Mortality of COVID-19 Patients: A Retrospective Cohort of 1792 Patients in Kenya.

Authors:  Isinta M Elijah; Endawoke Amsalu; Xuening Jian; Mingyang Cao; Eric K Mibei; Danvas O Kerosi; Francis G Mwatsahu; Wei Wang; Faith Onyangore; Youxin Wang
Journal:  Biosaf Health       Date:  2022-06-27

2.  Risk factors and outcomes associated with diabetes mellitus in COVID-19 patients: a meta-analytic synthesis of observational studies.

Authors:  Upasna Gaba; Mohammad Altamish; Md Azharuddin; Mohammad Adil; Pinaki Ghosh; Bishal Gyawali; Yogesh Yadav; Manju Sharma
Journal:  J Diabetes Metab Disord       Date:  2022-07-18

3.  Upregulation of TGF-β type II receptor in high glucose-induced vascular smooth muscle cells.

Authors:  Ghasem Ghasempour; Asghar Mohammadi; Fahimeh Zamani-Garmsiri; Ali Akbar Soleimani; Mohammad Najafi
Journal:  Mol Biol Rep       Date:  2022-01-23       Impact factor: 2.316

4.  Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia.

Authors:  Manal Faleh AlMutairi; Ayla M Tourkmani; Alian A Alrasheedy; Turki J ALHarbi; Abdulaziz M Bin Rsheed; Mohammed ALjehani; Yazed AlRuthia
Journal:  Ther Adv Chronic Dis       Date:  2021-09-08       Impact factor: 5.091

5.  Assessment of Mortality Rate, Need for ICU Admission and Ventilation in COVID-19 Patients with Diabetes Mellitus.

Authors:  Mehrnoosh Zakerkish; Maryam Shaabanpour Fooladi; Hajieh Bibi Shahbazian; Fatemeh Ahmadi; Seyed Peyman Payami; Mehrdad Dargahi-Malamir
Journal:  Qatar Med J       Date:  2022-03-01

6.  Predicting the Need for Intubation among COVID-19 Patients Using Machine Learning Algorithms: A Single-Center Study.

Authors:  Raoof Nopour; Mostafa Shanbehzadeh; Hadi Kazemi-Arpanahi
Journal:  Med J Islam Repub Iran       Date:  2022-04-04

Review 7.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.